Regulation of the host immune system by helminth parasites

Journal of Allergy and Clinical Immunology

Volumn 138, Issue 3, 2016, Pages 666-675

  Maizels, Rick M ^a   McSorley, Henry J ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Allergy; infection; pathology; therapy; tolerance

Indexed keywords

VACCINE;

ALLERGY; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; DENDRITIC CELL; EPITHELIUM CELL; GRAFT REJECTION; HELMINTH; HELMINTHIASIS; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ANIMAL; HOST PATHOGEN INTERACTION; HYPERSENSITIVITY; IMMUNOLOGY; NEOPLASM; PARASITE; REGULATORY B LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES, REGULATORY; DENDRITIC CELLS; HELMINTHIASIS; HELMINTHS; HOST-PATHOGEN INTERACTIONS; HUMANS; HYPERSENSITIVITY; IMMUNOMODULATION; MACROPHAGES; NEOPLASMS; PARASITES; T-LYMPHOCYTES, REGULATORY; VACCINES;

EID: 84995484395     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.07.007     Document Type: Article

References (166)

1. 1 McSorley, H.J., Maizels, R.M., Helminth infections and host immune regulation. Clin Microbial Rev 25 (2012), 585–608.
2. 2 Johnston, C.J., McSorley, H.J., Anderton, S.M., Wigmore, S.J., Maizels, R.M., Helminths and immunological tolerance. Transplantation 97 (2014), 127–132.
3. 3 Mishra, P.K., Palma, M., Bleich, D., Loke, P., Gause, W.C., Systemic impact of intestinal helminth infections. Mucosal Immunol 7 (2014), 753–762.
4. 4 Hotez, P.J., Brindley, P.J., Bethony, J.M., King, C.H., Pearce, E.J., Jacobson, J., Helminth infections: the great neglected tropical diseases. J Clin Invest 118 (2008), 1311–1321.
5. 5 Nutman, T.B., Kumaraswami, V., Ottesen, E.A., Parasite-specific anergy in human filariasis. Insights after analysis of parasite antigen-driven lymphokine production. J Clin Invest 79 (1987), 1516–1523.
6. 6 Maizels, R.M., Lawrence, R.A., Immunological tolerance: the key feature in human filariasis?. Parasitol Today 7 (1991), 271–276.
7. 7 King, C.L., Kumaraswami, V., Poindexter, R.W., Kumari, S., Jayaraman, K., Alling, D.W., et al. Immunologic tolerance in lymphatic filariasis. Diminished parasite-specific T and B cell lymphocyte precursor frequency in the microfilaremic state. J Clin Invest 89 (1992), 1403–1410.
8. 8 Piessens, W.F., McGreevy, P.B., Piessens, P.W., McGreevy, M., Koiman, I., Saroso, J.S., et al. Immune responses in human infections with Brugia malayi. Specific cellular unresponsiveness to filarial antigens. J Clin Invest 65 (1980), 172–179.
9. 9 Colley, D.G., Garcia, A.A., Lambertucci, J.R., Parra, J.C., Katz, N., Rocha, R.S., et al. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease. Am J Trop Med Hyg 35 (1986), 793–802.
10. 10 Sartono, E., Kruize, Y.C.M., Kurniawan, A., van der Meide, P.H., Partono, F., Maizels, R.M., et al. Elevated cellular responses and interferon-γ release after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis. J Infect Dis 171 (1995), 1683–1687.
11. + cells after chemotherapy in human Schistosoma haematobium infection. Eur J Immunol 26 (1996), 1365–1370.
12. 12 Mahanty, S., Mollis, S.N., Ravichandran, M., Abrams, J.S., Kumaraswami, V., Jayaraman, K., et al. High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis 173 (1996), 769–773.
13. h2 shift. Int Immunol 12 (2000), 623–630.
14. 14 Mbow, M., Larkin, B.M., Meurs, L., Wammes, L.J., de Jong, S.E., Labuda, L.A., et al. T-helper 17 cells are associated with pathology in human schistosomiasis. J Infect Dis 207 (2013), 186–195.
15. 15 Babu, S., Bhat, S.Q., Pavan Kumar, N., Lipira, A.B., Kumar, S., Karthik, C., et al. Filarial lymphedema is characterized by antigen-specific Th1 and Th17 proinflammatory responses and a lack of regulatory T cells. PLoS Negl Trop Dis, 3, 2009, e420.
16. 16 Sakaguchi, S., Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101 (2000), 455–458.
17. 17 Maizels, R.M., Smith, K.A., Regulatory T cells in infection. Adv Immunol 112 (2011), 73–136.
18. 18 Ludwig-Portugall, I., Layland, L.E., TLRs, Treg, and B cells, an interplay of regulation during helminth infection. Front Immunol, 3, 2012, 8.
19. 19 Metenou, S., Nutman, T., Regulatory T cell subsets in filarial infection and their function. Front Immunol, 4, 2013, 305.
20. 20 Labeaud, A.D., Malhotra, I., King, M.J., King, C.L., King, C.H., Do antenatal parasite infections devalue childhood vaccination?. PLoS Negl Trop Dis, 3, 2009, e442.
21. 21 Salgame, P., Yap, G.S., Gause, W.C., Effect of helminth-induced immunity on infections with microbial pathogens. Nat Immunol 14 (2013), 1118–1126.
22. 22 Hartgers, F.C., Obeng, B.B., Kruize, Y.C., Dijkhuis, A., McCall, M., Sauerwein, R.W., et al. Responses to malarial antigens are altered in helminth-infected children. J Infect Dis 199 (2009), 1528–1535.
23. 23 Dolo, H., Coulibaly, Y.I., Dembele, B., Konate, S., Coulibaly, S.Y., Doumbia, S.S., et al. Filariasis attenuates anemia and proinflammatory responses associated with clinical malaria: a matched prospective study in children and young adults. PLoS Negl Trop Dis, 6, 2012, e1890.
24. 24 Nash, T.E., Garcia, H.H., Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol 7 (2011), 584–594.
25. 25 Verma, A., Prasad, K.N., Cheekatla, S.S., Nyati, K.K., Paliwal, V.K., Gupta, R.K., Immune response in symptomatic and asymptomatic neurocysticercosis. Med Microbiol Immunol 200 (2011), 255–261.
26. 26 Tuero, I., Palma, S., Cabeza, F., Saleemi, S., Rodriguez, S., Gonzales, I., et al. A comparative study of peripheral immune responses to Taenia solium in individuals with parenchymal and subarachnoid neurocysticercosis. PLoS Negl Trop Dis, 9, 2015, e0004143.
27. 27 Lammie, P.J., Hitch, W.L., Walker Allen, E.M., Hightower, W., Eberhard, M.L., Maternal filarial infection as risk factor for infection in children. Lancet 337 (1991), 1005–1006.
28. 28 Steel, C., Guinea, A., McCarthy, J.S., Ottesen, E.A., Long-term effect of prenatal exposure to maternal microfilaraemia on immune responsiveness to filarial antigens. Lancet 343 (1994), 890–893.
29. 29 Mpairwe, H., Tweyongyere, R., Elliott, A., Pregnancy and helminth infections. Parasite Immunol 36 (2014), 328–337.
30. 30 Straubinger, K., Paul, S., Prazeres da Costa, O., Ritter, M., Buch, T., Busch, D.H., et al. Maternal immune response to helminth infection during pregnancy determines offspring susceptibility to allergic airway inflammation. J Allergy Clin Immunol 134 (2014), 1271–1279.e10.
31. 31 Weinstock, J.V., Elliott, D.E., Helminth infections decrease host susceptibility to immune-mediated diseases. J Immunol 193 (2014), 3239–3247.
32. 32 Li, Y., Chen, H.L., Bannick, N., Henry, M., Holm, A.N., Metwali, A., et al. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice. J Immunol 194 (2015), 1011–1020.
33. 33 Finlay, C.M., Walsh, K.P., Mills, K.H., Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases. Immunol Rev 259 (2014), 206–230.
34. 34 Watanabe, K., Mwinzi, P.N., Black, C.L., Muok, E.M., Karanja, D.M., Secor, W.E., et al. T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment. Am J Trop Med Hyg 77 (2007), 676–682.
35. 35 Wammes, L.J., Hamid, F., Wiria, A.E., Wibowo, H., Sartono, E., Maizels, R.M., et al. Regulatory T cells in human lymphatic filariasis: stronger functional activity in microfilaremics. PLoS Negl Trop Dis, 6, 2012, e1655.
36. 36 Metenou, S., Dembele, B., Konate, S., Dolo, H., Coulibaly, S.Y., Coulibaly, Y.I., et al. At homeostasis filarial infections have expanded adaptive T regulatory but not classical Th2 cells. J Immunol 184 (2010), 5375–5382.
37. 37 Katawa, G., Layland, L.E., Debrah, A.Y., von Horn, C., Batsa, L., Kwarteng, A., et al. Hyperreactive onchocerciasis is characterized by a combination of Th17-Th2 immune responses and reduced regulatory T cells. PLoS Negl Trop Dis, 9, 2015, e3414.
38. 38 Turner, J.D., Jackson, J.A., Faulkner, H., Behnke, J., Else, K., Kamgno, J., et al. Intensity of intestinal infection with multiple worm species is related to regulatory cytokine output and immune hyporesponsiveness. J Infect Dis 197 (2008), 1204–1212.
39. 39 Figueiredo, C.A., Barreto, M.L., Rodrigues, L.C., Cooper, P.J., Silva, N.B., Amorim, L.D., et al. Chronic intestinal helminth infections are associated with immune hyporesponsiveness and induction of a regulatory network. Infect Immun 78 (2010), 3160–3167.
40. 40 Satoguina, J., Mempel, M., Larbi, J., Badusche, M., Löliger, C., Adjei, O., et al. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect 4 (2002), 1291–1300.
41. 41 Satoguina, J.S., Weyand, E., Larbi, J., Hoerauf, A., T regulatory-1 cells induce IgG4 production by B cells: role of IL-10. J Immunol 174 (2005), 4718–4726.
42. 42 Satoguina, J.S., Adjobimey, T., Arndts, K., Hoch, J., Oldenburg, J., Layland, L.E., et al. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-β. Eur J Immunol 38 (2008), 3101–3113.
43. 43 van der Neut Kolfschoten, M., Schuurman, J., Losen, M., Bleeker, W.K., Martinez-Martinez, P., Vermeulen, E., et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317 (2007), 1554–1557.
44. 44 Grogan, J.L., Kremsner, P.G., van Dam, G.J., Metzger, W., Mordmüller, B., Deelder, A.M., et al. Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. J Infect Dis 173 (1996), 1242–1247.
45. 45 Grainger, J.R., Smith, K.A., Hewitson, J.P., McSorley, H.J., Harcus, Y., Filbey, K.J., et al. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. J Exp Med 207 (2010), 2331–2341.
46. 46 Zaccone, P., Burton, O., Miller, N., Jones, F.M., Dunne, D.W., Cooke, A., Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur J Immunol 39 (2009), 1098–1107.
47. + regulatory T cells that interfere with immune response and parasite clearance in BALB/c mice. J Immunol 186 (2011), 4295–4305.
48. 48 Sawant, D.V., Gravano, D.M., Vogel, P., Giacomin, P., Artis, D., Vignali, D.A.A., Regulatory T cells limit induction of protective immunity and promote immune pathology following intestinal helminth infection. J Immunol 192 (2014), 2904–2912.
49. 49 Smith, K.A., Filbey, K.J., Reynolds, L.A., Hewitson, J.P., Harcus, Y., Boon, L., et al. Low level regulatory T cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths. Mucosal Immunol 9 (2016), 428–443.
50. 50 Taylor, M., Le Goff, L., Harris, A., Malone, E., Allen, J.E., Maizels, R.M., Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J Immunol 174 (2005), 4924–4933.
51. 51 Taylor, M.D., van der Werf, N., Maizels, R.M., T cells in helminth infection: the regulators and the regulated. Trends Immunol 33 (2012), 181–189.
52. 52 Wilson, M.S., Taylor, M., Balic, A., Finney, C.A.M., Lamb, J.R., Maizels, R.M., Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 202 (2005), 1199–1212.
53. 53 Layland, L.E., Straubinger, K., Ritter, M., Loffredo-Verde, E., Garn, H., Sparwasser, T., et al. Schistosoma mansoni-mediated suppression of allergic airway inflammation requires patency and Foxp3+ Treg cells. PLoS Negl Trop Dis, 7, 2013, e2379.
54. 54 D'Elia, R., Behnke, J.M., Bradley, J.E., Else, K.J., Regulatory T cells: a role in the control of helminth driven intestinal pathology and worm survival. J Immunol 182 (2009), 2340–2348.
55. 55 Wammes, L.J., Hamid, F., Wiria, A.E., de Gier, B., Sartono, E., Maizels, R.M., et al. Regulatory T cell in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum. Eur J Immunol 40 (2010), 437–442.
56. 56 Elias, D., Britton, S., Aseffa, A., Engers, H., Akuffo, H., Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-β production. Vaccine 26 (2008), 3897–3902.
57. + T-cell response is increased, and Treg cells decreased, in anthelmintic-treated patients with latent TB. Eur J Immunol 46 (2016), 752–761.
58. 58 Hussaarts, L., van der Vlugt, L.E., Yazdanbakhsh, M., Smits, H.H., Regulatory B-cell induction by helminths: implications for allergic disease. J Allergy Clin Immunol 128 (2011), 733–739.
59. hi B cells modulate experimental allergic and autoimmune inflammation. Eur J Immunol 40 (2010), 1682–1696.
60. 60 van der Vlugt, L.E., Labuda, L.A., Ozir-Fazalalikhan, A., Lievers, E., Gloudemans, A.K., Liu, K.Y., et al. Schistosomes induce regulatory features in human and mouse CD1d B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS One, 7, 2012, e30883.
61. 61 Correale, J., Farez, M., Razzitte, G., Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol 64 (2008), 187–199.
62. 62 Akdis, M., Akdis, C.A., Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 133 (2014), 621–631.
63. 63 Perona-Wright, G., Jenkins, S.J., MacDonald, A.S., Dendritic cell activation and function in response to Schistosoma mansoni. Int J Parasitol 36 (2006), 711–721.
64. 64 Everts, B., Smits, H.H., Hokke, C.H., Yazdankbakhsh, M., Sensing of helminth infections by dendritic cells via pattern recognition receptors and beyond: consequences for T helper 2 and regulatory T cell polarization. Eur J Immunol 40 (2010), 1525–1537.
65. 65 Tussiwand, R., Everts, B., Grajales-Reyes, G.E., Kretzer, N.M., Iwata, A., Bagaitkar, J., et al. Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses. Immunity 42 (2015), 916–928.
66. 66 Jenkins, S.J., Perona-Wright, G., Worsley, A.G., Ishii, N., MacDonald, A.S., Dendritic cell expression of OX40 ligand acts as a costimulatory, not polarizing, signal for optimal Th2 priming and memory induction in vivo. J Immunol 179 (2007), 3515–3523.
67. − DC population. J Immunol 186 (2011), 7098–7109.
68. 68 Blum, A.M., Hang, L., Setiawan, T., Urban, J.P. Jr., Stoyanoff, K.M., Leung, J., et al. Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses. J Immunol 189 (2012), 2512–2520.
69. 69 Balic, A., Harcus, Y., Holland, M.J., Maizels, R.M., Selective maturation of dendritic cells by Nippostrongylus brasiliensis secreted proteins drives T helper type 2 immune responses. Eur J Immunol 34 (2004), 3047–3059.
70. 70 Cervi, L., MacDonald, A.S., Kane, C., Dzierszinski, F., Pearce, E.J., Dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J Immunol 172 (2004), 2016–2020.
71. 71 Segura, M., Su, Z., Piccirillo, C., Stevenson, M.M., Impairment of dendritic cell function by excretory-secretory products: a potential mechanism for nematode-induced immunosuppression. Eur J Immunol 37 (2007), 1887–1904.
72. 72 Matisz, C.E., Leung, G., Reyes, J.L., Wang, A., Sharkey, K.A., McKay, D.M., Adoptive transfer of helminth antigen-pulsed dendritic cells protects against the development of experimental colitis in mice. Eur J Immunol 45 (2015), 3126–3139.
73. 73 Everts, B., Hussaarts, L., Driessen, N.N., Meevissen, M.H., Schramm, G., van der Ham, A.J., et al. Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. J Exp Med 209 (2012), 1753–1767.
74. 74 Martinez, F.O., Helming, L., Gordon, S., Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27 (2009), 451–483.
75. 75 Nair, M.G., Gallagher, I.J., Taylor, M.D., Loke, P., Coulson, P.S., Wilson, R.A., et al. Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun 73 (2005), 385–394.
76. H2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med 12 (2006), 955–960.
77. 77 Filbey, K.J., Grainger, J.R., Smith, K.A., Boon, L., van Rooijen, N., Harcus, Y., et al. Innate and adaptive type 2 immune cell responses in genetically controlled resistance to intestinal helminth infection. Immunol Cell Biol 92 (2014), 436–448.
78. 78 Gause, W.C., Wynn, T.A., Allen, J.E., Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat Rev Immunol 13 (2013), 607–614.
79. 79 MacDonald, A.S., Maizels, R.M., Lawrence, R.A., Dransfield, I., Allen, J.E., Requirement for in vivo production of IL-4, but not IL-10, in the induction of proliferative suppression by filarial parasites. J Immunol 160 (1998), 4124–4132.
80. 80 Terrazas, L.I., Montero, D., Terrazas, C.A., Reyes, J.L., Rodriguez-Sosa, M., Role of the programmed death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis. Int J Parasitol 35 (2005), 1349–1358.
81. 81 Broadhurst, M.J., Leung, J., Lim, K.C., Girgis, N., Gundra, U.M., Fallon, P., et al. Upregulation of retinal dehydrogenase 2 in alternatively activated macrophages during retinoid-dependent Type-2 immunity to helminth infection in mice. PLoS Pathog, 8, 2012, e1002883.
82. 82 Hewitt, E.W., The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110 (2003), 163–169.
83. 83 Greenwood, B.M., Autoimmune disease and parasitic infections in Nigerians. Lancet 2 (1968), 380–382.
84. 84 van den Biggelaar, A.H., Rodrigues, L.C., van Ree, R., van der Zee, J.S., Hoeksma-Kruize, Y.C., Souverijn, J.H., et al. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis 189 (2004), 892–900.
85. 85 Feary, J., Britton, J., Leonardi-Bee, J., Atopy and current intestinal parasite infection: a systematic review and meta-analysis. Allergy 66 (2011), 569–578.
86. 86 Mutapi, F., Imai, N., Nausch, N., Bourke, C.D., Rujeni, N., Mitchell, K.M., et al. Schistosome infection intensity is inversely related to auto-reactive antibody levels. PLoS One, 6, 2011, e19149.
87. 87 McKay, D.M., Not all parasites are protective. Parasite Immunol 37 (2015), 324–332.
88. 88 Smits, H.H., Hartgers, F.C., Yazdanbakhsh, M., Helminth infections: protection from atopic disorders. Curr Allergy Asthma Rep 5 (2005), 42–50.
89. 89 Maizels, R.M., McSorley, H.J., Smyth, D.J., Helminths in the hygiene hypothesis—sooner or later?. Clin Exp Immunol 177 (2014), 38–46.
90. 90 Weinstock, J.V., Elliott, D.E., Translatability of helminth therapy in inflammatory bowel diseases. Int J Parasitol 43 (2013), 245–251.
91. 91 Correale, J., Farez, M., Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 61 (2007), 97–108.
92. 92 Correale, J., Farez, M.F., The impact of parasite infections on the course of multiple sclerosis. J Neuroimmunol 233 (2011), 6–11.
93. 93 Smits, H.H., Everts, B., Hartgers, F.C., Yazdanbakhsh, M., Chronic helminth infections protect against allergic diseases by active regulatory processes. Curr Allergy Asthma Rep 10 (2010), 3–12.
94. 94 Evans, H., Mitre, E., Worms as therapeutics for allergy: understanding why benefits in animal studies have not translated into clinical success. J Allergy Clin Immunol 135 (2015), 343–353.
95. 95 Amu, S., Saunders, S.P., Kronenberg, M., Mangan, N.E., Atzberger, A., Fallon, P.G., Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol 125 (2010), 1114–1124.
96. 96 Smith, P., Mangan, N.E., Walsh, C.M., Fallon, R.E., McKenzie, A.N.J., van Rooijen, N., et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol 178 (2007), 4557–4566.
97. 97 Summers, R.W., Elliott, D.E., Urban, J.F. Jr., Thompson, R.A., Weinstock, J.V., Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128 (2005), 825–832.
98. 98 Bager, P., Arnved, J., Rønborg, S., Wohlfahrt, J., Poulsen, L.K., Westergaard, T., et al. Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial. J Allergy Clin Immunol 125 (2010), 123–130.
99. 99 Garg, S.K., Croft, A.M., Bager, P., Helminth therapy (worms) for induction of remission in inflammatory bowel disease. Cochrane Database Syst Rev(1), 2014, CD009400.
100. 100 Daniłowicz-Luebert, E., O'Regan, N.L., Steinfelder, S., Hartmann, S., Modulation of specific and allergy-related immune responses by helminths. J Biomed Biotechnol, 2011, 2011, 821578.
101. 101 McSorley, H.J., Hewitson, J.P., Maizels, R.M., Immunomodulation by helminth parasites: Defining mechanisms and mediators. Int J Parasitol 43 (2013), 301–310.
102. 102 Shepherd, C., Navarro, S., Wangchuk, P., Wilson, D., Daly, N.L., Loukas, A., Identifying the immunomodulatory components of helminths. Parasite Immunol 37 (2015), 293–303.
103. 103 McSorley, H.J., Blair, N.F., Smith, K.A., McKenzie, A.N.J., Maizels, R.M., Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy. Mucosal Immunol 7 (2014), 1068–1078.
104. 104 Schnoeller, C., Rausch, S., Pillai, S., Avagyan, A., Wittig, B.M., Loddenkemper, C., et al. A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol 180 (2008), 4265–4272.
105. 105 Hams, E., Bermingham, R., Wurlod, F.A., Hogan, A.E., O'Shea, D., Preston, R.J., et al. The helminth T2 RNase omega1 promotes metabolic homeostasis in an IL-33- and group 2 innate lymphoid cell-dependent mechanism. FASEB J 30 (2016), 824–835.
106. 106 Marshall, F.A., Watson, K.A., Garside, P., Harnett, M.M., Harnett, W., Effect of activated antigen-specific B cells on ES-62-mediated modulation of effector function of heterologous antigen-specific T cells in vivo. Immunology 123 (2008), 411–425.
107. 107 Harnett, W., Goodridge, H.S., Allen, J.M., Harnett, M., Receptor usage by the Acanthocheilonema viteae-derived immunomodulator, ES-62. Exp Parasitol 132 (2012), 97–102.
108. 108 Aprahamian, T.R., Zhong, X., Amir, S., Binder, C.J., Chiang, L.K., Al-Riyami, L., et al. The immunomodulatory parasitic worm product ES-62 reduces lupus-associated accelerated atherosclerosis in a mouse model. Int J Parasitol 45 (2015), 203–207.
109. + T cells. Eur J Immunol 41 (2011), 2709–2718.
110. 110 Robinson, M.W., Donnelly, S., Hutchinson, A.T., To, J., Taylor, N.L., Norton, R.S., et al. A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides. PLOS Pathogens, 7, 2011, e1002042.
111. 111 Robinson, M.W., Alvarado, R., To, J., Hutchinson, A.T., Dowdell, S.N., Lund, M., et al. A helminth cathelicidin-like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPase. FASEB J 26 (2012), 4614–4627.
112. 112 Manoury, B., Gregory, W.F., Maizels, R.M., Watts, C., Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Curr Biol 11 (2001), 447–451.
113. 113 Dainichi, T., Maekawa, Y., Ishii, K., Zhang, T., Nashed, B.F., Sakai, T., et al. Nippocystatin, a cysteine protease inhibitor from Nippostrongylus brasiliensis, inhibits antigen processing and modulates antigen- specific immune response. Infect Immun 69 (2001), 7380–7386.
114. 114 Klotz, C., Ziegler, T., Figueiredo, A.S., Rausch, S., Hepworth, M.R., Obsivac, N., et al. A helminth immunomodulator exploits host signaling events to regulate cytokine production in macrophages. PLoS Pathog, 7, 2011, e1001248.
115. + T cells and protects against mucosal inflammation. J Immunol 194 (2015), 1555–1564.
116. 116 Huang, L., Appleton, J.A., Eosinophils in helminth infection: defenders and dupes. Trends Parasitol, 2016 [Epub ahead of print].
117. 117 McSorley, H.J., O'Gorman, M.T., Blair, N., Sutherland, T.E., Filbey, K.J., Maizels, R.M., Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus. Eur J Immunol 42 (2012), 2667–2682.
118. 118 Trujillo-Vargas, C.M., Werner-Klein, M., Wohlleben, G., Polte, T., Hansen, G., Ehlers, S., et al. Helminth derived products inhibit the development of allergic responses in mice. Am J Respir Cell Mol Biol 175 (2007), 336–344.
119. 119 Schabussova, I., Ul-Haq, O., Hoflehner, E., Akgün, J., Wagner, A., Loupal, G., et al. Oesophagostomum dentatum extract modulates T cell-dependent immune responses to bystander antigens and prevents the development of allergy in mice. PLoS One, 8, 2013, e67544.
120. 120 Reynolds, L.A., Finlay, B.B., Maizels, R.M., Cohabitation in the intestine: interactions among helminth parasites, bacterial microbiota, and host immunity. J Immunol 195 (2015), 4059–4066.
121. 121 Gause, W.C., Maizels, R.M., Macrobiota—helminths as active participants and partners of the microbiota in host intestinal homeostasis. Curr Opin Microbiol 32 (2016), 14–18.
122. 122 Zaiss, M.M., Harris, N.L., Interactions between the intestinal microbiome and helminth parasites. Parasite Immunol 38 (2016), 5–11.
123. 123 Walk, S.T., Blum, A.M., Ewing, S.A., Weinstock, J.V., Young, V.B., Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm Bowel Dis 16 (2010), 1841–1849.
124. 124 Reynolds, L.A., Smith, K.A., Filbey, K.J., Harcus, Y., Hewitson, J.P., Yebra, M., et al. Commensal-pathogen interactions in the intestinal tract: lactobacilli promote infection with, and are promoted by, helminth parasites. Gut Microbes 5 (2014), 10–19.
125. 125 Holm, J.B., Sorobetea, D., Kiilerich, P., Ramayo-Caldas, Y., Estelle, J., Ma, T., et al. Chronic Trichuris muris infection decreases diversity of the intestinal microbiota and concomitantly increases the abundance of lactobacilli. PLoS One, 10, 2015, e0125495.
126. 126 Houlden, A., Hayes, K.S., Bancroft, A.J., Worthington, J.J., Wang, P., Grencis, R.K., et al. Chronic Trichuris muris infection in C57BL/6 mice causes significant changes in host microbiota and metabolome: effects reversed by pathogen clearance. PLoS One, 10, 2015, e0125945.
127. 127 Zaiss, M.M., Rapin, A., Lebon, L., Dubey, L.K., Mosconi, I., Sarter, K., et al. The intestinal microbiota contributes to the ability of helminths to modulate allergic inflammation. Immunity 43 (2015), 998–1010.
128. 128 Ohnmacht, C., Park, J.H., Cording, S., Wing, J.B., Atarashi, K., Obata, Y., et al. The microbiota regulates type 2 immunity through RORgammat+ T cells. Science 349 (2015), 989–993.
129. 129 Brestoff, J.R., Artis, D., Immune regulation of metabolic homeostasis in health and disease. Cell 161 (2015), 146–160.
130. 130 Odegaard, J.I., Chawla, A., Type 2 responses at the interface between immunity and fat metabolism. Curr Opin Immunol 36 (2015), 67–72.
131. 131 Wiria, A.E., Sartono, E., Supali, T., Yazdanbakhsh, M., Helminth infections, type-2 immune response, and metabolic syndrome. PLoS Pathog, 10, 2014, e1004140.
132. 132 Wu, D., Molofsky, A.B., Liang, H.E., Ricardo-Gonzalez, R.R., Jouihan, H.A., Bando, J.K., et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332 (2011), 243–247.
133. 133 Hussaarts, L., Garcia-Tardon, N., van Beek, L., Heemskerk, M.M., Haeberlein, S., van der Zon, G.C., et al. Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice. FASEB J 29 (2015), 3027–3039.
134. 134 Herrera, L.A., Ostrosky-Wegman, P., Do helminths play a role in carcinogenesis?. Trends Parasitol 17 (2001), 172–175.
135. 135 Mayer, D.A., Fried, B., The role of helminth infections in carcinogenesis. Adv Parasitol 65 (2007), 239–296.
136. 136 Honeycutt, J., Hammam, O., Fu, C.L., Hsieh, M.H., Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer. Trends Parasitol 30 (2014), 324–332.
137. 137 Smout, M.J., Laha, T., Mulvenna, J., Sripa, B., Suttiprapa, S., Jones, A., et al. A granulin-like growth factor secreted by the carcinogenic liver fluke, Opisthorchis viverrini, promotes proliferation of host cells. PLoS Pathog, 5, 2009, e1000611.
138. 138 Smout, M.J., Sotillo, J., Laha, T., Papatpremsiri, A., Rinaldi, G., Pimenta, R.N., et al. Carcinogenic parasite secretes growth factor that accelerates wound healing and potentially promotes neoplasia. PLoS Pathog, 11, 2015, e1005209.
139. 139 Wang, X., Chen, W., Huang, Y., Sun, J., Men, J., Liu, H., et al. The draft genome of the carcinogenic human liver fluke Clonorchis sinensis. Genome Biol, 12, 2011, R107.
140. 140 Sripa, B., Brindley, P.J., Mulvenna, J., Laha, T., Smout, M.J., Mairiang, E., et al. The tumorigenic liver fluke Opisthorchis viverrini—multiple pathways to cancer. Trends Parasitol 28 (2012), 395–407.
141. 141 Saleem, S.J., Martin, R.K., Morales, J.K., Sturgill, J.L., Gibb, D.R., Graham, L., et al. Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity. J Immunol 189 (2012), 511–515.
142. 142 Morales, J.K., Saleem, S.J., Martin, R.K., Saunders, B.L., Barnstein, B.O., Faber, T.W., et al. Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses. J Leukoc Biol 95 (2014), 643–650.
143. + Th2 responses and promote chronic infection. Mucosal Immunol, 2016 [Epub ahead of print].
144. 144 Kumar, V., Patel, S., Tcyganov, E., Gabrilovich, D.I., The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol 37 (2016), 208–220.
145. 145 van der Burg, S.H., Arens, R., Ossendorp, F., van Hall, T., Melief, C.J., Vaccines for established cancer: overcoming the challenges posed by immune evasion. Nat Rev Cancer 16 (2016), 219–233.
146. 146 Saenz, S.A., Taylor, B.C., Artis, D., Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev 226 (2008), 172–190.
147. 147 Hammad, H., Lambrecht, B.N., Barrier epithelial cells and the control of type 2 immunity. Immunity 43 (2015), 29–40.
148. 148 Hammad, H., Chieppa, M., Perros, F., Willart, M.A., Germain, R.N., Lambrecht, B.N., House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 15 (2009), 410–416.
149. 149 Willart, M.A., Deswarte, K., Pouliot, P., Braun, H., Beyaert, R., Lambrecht, B.N., et al. Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med 209 (2012), 1505–1517.
150. 150 Maizels, R.M., Hewitson, J.P., Smith, K.A., Susceptibility and immunity to helminth parasites. Curr Opin Immunol 25 (2012), 459–466.
151. 151 Ajendra, J., Specht, S., Neumann, A.L., Gondorf, F., Schmidt, D., Gentil, K., et al. ST2 deficiency does not impair type 2 immune responses during chronic filarial infection but leads to an increased microfilaremia due to an impaired splenic microfilarial clearance. PLoS One, 9, 2014, e93072.
152. 152 Hung, L.Y., Lewkowich, I.P., Dawson, L.A., Downey, J., Yang, Y., Smith, D.E., et al. IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms. Proc Natl Acad Sci U S A 110 (2013), 282–287.
153. 153 Scalfone, L.K., Nel, H.J., Gagliardo, L.F., Cameron, J.L., Al-Shokri, S., Leifer, C.A., et al. Participation of MyD88 and interleukin-33 as innate drivers of Th2 immunity to Trichinella spiralis. Infect Immun 81 (2013), 1354–1363.
154. 154 Yang, Z., Grinchuk, V., Urban, J.F. Jr., Bohl, J., Sun, R., Notari, L., et al. Macrophages as IL-25/IL-33-responsive cells play an important role in the induction of type 2 immunity. PLoS One, 8, 2013, e59441.
155. 155 Bouchery, T., Kyle, R., Camberis, M., Shepherd, A., Filbey, K., Smith, A., et al. ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nat Commun, 6, 2015, 6970.
156. 156 Yasuda, K., Muto, T., Kawagoe, T., Matsumoto, M., Sasaki, Y., Matsushita, K., et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci U S A 109 (2012), 3451–3456.
157. 157 Humphreys, N.E., Xu, D., Hepworth, M.R., Liew, F.Y., Grencis, R.K., IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol 180 (2008), 2443–2449.
158. 158 Buck, A.H., Coakley, G., Simbari, F., Kumar, S., Lear, M., Abreu-Goodget, C., et al. Exosomes secreted by a nematode parasite transfer RNA to mammalian cells and regulate genes of the innate immune system. Nat Commun, 5, 2014, 5488.
159. 159 Hewitson, J.P., Filbey, K.J., Esser-von Bieren, J., Camberis, M., Schwartz, C., Murray, J., et al. Concerted activity of IgG1 antibodies and IL-4/IL-25-dependent effector cells trap helminth larvae in the tissues following vaccination with defined secreted antigens, providing sterile immunity to challenge infection. PLoS Pathog, 11, 2015, e1004676.
160. 160 Zaiss, M.M., Maslowski, K.M., Mosconi, I., Guenat, N., Marsland, B.J., Harris, N.L., IL-1β suppresses innate IL-25 and IL-33 production and maintains helminth chronicity. PLoS Pathog, 9, 2013, e1003531.
161. 161 Mearns, H., Forbes-Blom, E.E., Camberis, M., Tang, S.C., Kyle, R., Harvie, M., et al. IL-25 exhibits disparate roles during Th2-cell differentiation versus effector function. Eur J Immunol 44 (2014), 1976–1980.
162. 162 Gerbe, F., Sidot, E., Smyth, D.J., Ohmoto, M., Matsumoto, I., Dardalhon, V., et al. Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites. Nature 529 (2016), 226–230.
163. 163 von Moltke, J., Ji, M., Liang, H.E., Locksley, R.M., Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature 529 (2016), 221–225.
164. 164 Howitt, M.R., Lavoie, S., Michaud, M., Blum, A.M., Tran, S.V., Weinstock, J.V., et al. Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut. Science 351 (2016), 1329–1333.
165. 165 Diemert, D.J., Pinto, A.G., Freire, J., Jariwala, A., Santiago, H., Hamilton, R.G., et al. Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths. J Allergy Clin Immunol 130 (2012), 169–176.e6.
166. 166 Hewitson, J.P., Filbey, K.J., Grainger, J.R., Dowle, A.A., Pearson, M., Murray, J., et al. Heligmosomoides polygyrus elicits a dominant nonprotective antibody response directed at restricted glycan and peptide epitopes. J Immunol 187 (2011), 4764–4777.